CARE ONCOLOGY CLINICS PROTOKOLL:
Metformin:
”How diabetes drug metformin inhibits progression of pancreatic cancer”
Doxycyline:
”Doxycycline Induces Apoptosis in PANC-1 Pancreatic Cancer Cells”
Mebendazole:
“Repositioning approved drugs for the treatment of problematic cancers using a screening approach”
Statiner:
“Statins & Metformin Help Pancreatic Cancer Patients”
”STATINS ASSOCIATED WITH 56% REDUCTION OF PANCREATIC CANCER RISK IN MEN”
”Statin Use and Its Impact on Survival in Pancreatic Cancer Patients”
ANDRA LÄKEMEDEL/TILLSKOTT:
Propranolol:
Disulfiram (Antabus):
”Ny studie: Antabus effektivt mot cancer”
Atorvastatin, Celecoxib, Tipifarnib:
Diclofenac:
Curcumin:
“Phase II trial of curcumin in patients with advanced pancreatic cancer”
Vitamin A:
“Vitamin A may help improve pancreatic cancer chemotherapy”
Artesunate:
Hydroxychloroquine:
“Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer”
Dipyridamole:
FALLSTUDIE:
Fyra ukspottskörtelcancerpatienter som svarat extremt väl på behandling med ALA och Naltrexon presenteras i följande två fallstudier: